Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats | Zendy

JeanFrançois Marier | Zendy

Open Access

Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats

Author(s) -

JeanFrançois Marier

Publication year - 2003

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkg317

Subject(s) - tobramycin , pharmacokinetics , pseudomonas aeruginosa , pharmacology , medicine , antibacterial agent , aminoglycoside , minimum inhibitory concentration , cystic fibrosis , antibiotics , microbiology and biotechnology , chemistry , biology , bacteria , genetics

To determine the pharmacokinetics and efficacy of tobramycin against pulmonary infections of Pseudomonas aeruginosa in rats after intratracheal administration of conventional and liposomal formulations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research